Eli Lilly and Novo Nordisk the pharmaceutical heavyweights selling popular weight-loss injections are each dangling discounts to gain an edge and to ...

Eli Lilly is requesting medical records from patients who took compounded versions of tirzepatide amid safety concerns and ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.81% and ...

Although originally prescribed to treat type 2 diabetes (Ozempic and Mounjaro), semaglutide and tirzepatide are becoming more ...

Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...

Ozempic, Mounjaro, Wegovy…the so-called miracle drugs that are changing how diabetes and obesity are treated. One in eight ...

Eli Lilly stock may look expensive, but that may not be the case in a few years as the business grows at a rapid pace.

Ozempic, Wegovy, Zepbound, and Mounjaro are but a few of the injectable drugs that are currently revolutionizing the size of ...

Although originally prescribed to treat type 2 diabetes (Ozempic and Mounjaro), semaglutide and tirzepatide are becoming more ...

How Hollywood is putting their best face forward – using recycled fat! When it comes to losing weight, it’s no secret many have turned to drugs like Ozempic and Mounjaro… but Beverly Hills plastic ...

Many GLP-1 users suddenly discover they don't have as much "food noise" or constant thoughts about eating anymore. They also ...

Meanwhile, Lilly’s 2023 revenue exceeded $34 billion, growing 20% year-over-year. Its tirzepatide brands Mounjaro and ...